Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

After-hours movers: Guardant Health sinks on colorectal cancer test data, Adobe jumps on EPS

Published 15/12/2022, 22:56
© Reuters.
ADBE
-
X
-
EXAS
-
GH
-
AGFY
-

By Investing.com Staff

After-Hours Stock Movers:

Guardant Health (NASDAQ:GH) 41% LOWER; announced results from ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode), an over 20,000 patient registrational study evaluating the performance of its blood test for detecting colorectal cancer (CRC) in average-risk adults. The test demonstrated 83% sensitivity in detecting individuals with CRC. Specificity was 90% in both individuals without advanced neoplasia and in those who had a negative colonoscopy result. This test also demonstrated 13% sensitivity in detecting advanced adenomas.

Agrify Corp (NASDAQ:AGFY27% LOWER; announced the launch of an underwritten public offering of shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, and accompanying warrants to purchase its common stock.

Exact Sciences Corporation (NASDAQ:EXAS) 26% HIGHER; jumps following the ECLIPSE results from rival GH.

Adobe Systems (NASDAQ:ADBE) 6% HIGHER; reported Q4 EPS of $3.60, $0.10 better than the analyst estimate of $3.50. Revenue for the quarter came in at $4.53 billion versus the consensus estimate of $4.53B. Adobe Systems sees FY2023 EPS of $15.15-$15.45, versus the consensus of $15.25. Adobe Systems sees FY2023 revenue of $19.1-19.3B, versus the consensus of $19.37B. Adobe Systems sees Q1 2023 EPS of $3.65-$3.70, versus the consensus of $3.64. Adobe Systems sees Q1 2023 revenue of $4.6-4.64B, versus the consensus of $4.64B.

United States Steel Corporation (NYSE:X) 3% HIGHER; provided fourth quarter 2022 guidance. Fourth quarter 2022 adjusted EBITDA is expected to be approximately $375 million. Fourth quarter 2022 adjusted net earnings per diluted share is expected to be in the range of $0.58 to $0.63.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.